Frank Torti
CIK 1647805 · President and Vant Chair · last filed 2026-07-02
Frank Torti is a President and Vant Chair who has filed 33 SEC Form 4 insider transactions across 8 companies since 2018. The most recent filing shows the insider had shares withheld for taxes covering $1.4M of ROIV on Jul 2, 2026. Across all open-market trades the lifetime net is −$81.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $550.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$550.56M
8
33
-$81.92M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President and Vant Chair | 13,536,202 | $37.37 | $505.85M | -$82.04M | 5 | 2026-07-02 |
| IMVT | Director | 1,009,228 | $44.30 | $44.71M | $116.2K | 8 | 2026-04-09 |
| ABUS | Director | — | $4.84 | — | $0 | 7 | 2024-05-24 |
| Sio Gene Therapies Inc. (SIOX) Delisted | Director | — | $0.48 | — | $0 | 1 | 2021-04-19 |
| Immunovant, Inc. (IMVTW) Delisted | Director | 28,400 | — | — | $0 | 2 | 2020-05-18 |
| Sio Gene Therapies Inc. (AXGT) Delisted | Director | — | — | — | $0 | 1 | 2020-04-17 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | — | $26.98 | — | $0 | 2 | 2019-08-27 |
| Urovant Sciences Ltd. (UROV) Delisted | Director | — | $16.24 | — | $0 | 2 | 2019-07-11 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-02 | ROIV | Tax (F) | −40,310 | -$1.43M | EDGAR |
| 2026-04-09 | IMVT | Grant (A) | +174,189 | $0 | EDGAR |
| 2026-04-02 | ROIV | Tax (F) | −160,035 | -$4.43M | EDGAR |
| 2026-02-23 | ROIV | Mixed | — | -$70.49M | EDGAR |
| 2026-02-20 | ROIV | Notice (144) | −1,600,000 | -$44.03M | EDGAR |
| 2026-02-19 | ROIV | Notice (144) | −1,400,000 | -$38.47M | EDGAR |
| 2025-12-29 | ROIV | Notice (144) | −64,891 | -$1.46M | EDGAR |
| 2025-12-29 | ROIV | Mixed | — | $2.48M | EDGAR |
| 2025-08-01 | ROIV | Grant (A) | +13,736,547 | $0 | EDGAR |
| 2025-04-03 | IMVT | Grant (A) | +199,365 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.